203 related articles for article (PubMed ID: 17426784)
1. Evaluation of urine N1,N12-Diacetylspermine as potential tumor marker for urinary bladder cancer.
Stejskal D; Humenanska V; Hanulova Z; Fiala R; Vrtal R; Solichova P; Karpisek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):235-7. PubMed ID: 17426784
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.
Enjoji M; Nakamuta M; Arimura E; Morizono S; Kuniyoshi M; Fukushima M; Kotoh K; Nawata H
Int J Biol Markers; 2004; 19(4):322-7. PubMed ID: 15646840
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of an ELISA system of N1,N12-diacetylspermine in human urine].
Matsuoka A; Sakamoto T
Rinsho Byori; 2004 Apr; 52(4):328-31. PubMed ID: 15164600
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric separation and determination of N1,N12-diacetylspermine in the urine of cancer patients.
Kobayashi M; Samejima K; Hiramatsu K; Kawakita M
Biol Pharm Bull; 2002 Mar; 25(3):372-4. PubMed ID: 11913536
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of urine N1, N12-diacetylspermine in patients with non-small cell lung cancer.
Kato M; Onishi H; Matsumoto K; Motoshita J; Tsuruta N; Higuchi K; Katano M
Anticancer Res; 2014 Jun; 34(6):3053-9. PubMed ID: 24922672
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancers.
Umemori Y; Ohe Y; Kuribayashi K; Tsuji N; Nishidate T; Kameshima H; Hirata K; Watanabe N
Clin Chim Acta; 2010 Dec; 411(23-24):1894-9. PubMed ID: 20655890
[TBL] [Abstract][Full Text] [Related]
7. Two enzyme-linked immunosorbent assay (ELISA) systems for N1,N8-diacetylspermidine and N1,N12-diacetylspermine using monoclonal antibodies.
Hamaoki M; Hiramatsu K; Suzuki S; Nagata A; Kawakita M
J Biochem; 2002 Nov; 132(5):783-8. PubMed ID: 12417029
[TBL] [Abstract][Full Text] [Related]
8. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker].
Kawakita M; Hiramatsu K; Takahashi K; Yamada R; Kawaguchi M; Shinoura N; Tanaka T; Kariyone K; Tamamori Y; Sasaki Y; Mori T
Rinsho Byori; 2005 Feb; 53(2):123-9. PubMed ID: 15796045
[TBL] [Abstract][Full Text] [Related]
9. Significance of urinary N1,N8-diacetylspermidine and N1,N12-diacetylspermine as indicators of neoplastic diseases.
Sugimoto M; Hiramatsu K; Kamei S; Kinoshita K; Hoshino M; Iwasaki K; Kawakita M
J Cancer Res Clin Oncol; 1995; 121(5):317-9. PubMed ID: 7768972
[TBL] [Abstract][Full Text] [Related]
10. Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.
Takahashi Y; Sakaguchi K; Horio H; Hiramatsu K; Moriya S; Takahashi K; Kawakita M
Br J Cancer; 2015 Nov; 113(10):1493-501. PubMed ID: 26505680
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic usefulness of N1,N8-diacetylspermidine and N1,N12-diacetylspermine in urine as novel markers of malignancy.
Hiramatsu K; Sugimoto M; Kamei S; Hoshino M; Kinoshita K; Iwasaki K; Kawakita M
J Cancer Res Clin Oncol; 1997; 123(10):539-45. PubMed ID: 9393587
[TBL] [Abstract][Full Text] [Related]
12. Preparation of monoclonal antibodies against N-(gamma-maleimidobutyryloxy)succinimide (GMBS)-conjugated acetylspermine, and development of an enzyme-linked immunosorbent assay (ELISA) for N1,N12-diacetylspermine.
Fujiwara K; Kaminishi Y; Kitagawa T; Tsuru D; Yabuuchi M; Kanetake H; Nomata K
J Biochem; 1998 Jul; 124(1):244-9. PubMed ID: 9644270
[TBL] [Abstract][Full Text] [Related]
13. Polyamine profiles in the urine of patients with leukemia.
Lee SH; Suh JW; Chung BC; Kim SO
Cancer Lett; 1998 Jan; 122(1-2):1-8. PubMed ID: 9464484
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer.
Stejskal D; Fiala RR
Neoplasma; 2006; 53(4):343-6. PubMed ID: 16830064
[TBL] [Abstract][Full Text] [Related]
15. Development of a sensitive and accurate enzyme-linked immunosorbent assay (ELISA) system that can replace HPLC analysis for the determination of N1,N12-diacetylspermine in human urine.
Hiramatsu K; Miura H; Kamei S; Iwasaki K; Kawakita M
J Biochem; 1998 Jul; 124(1):231-6. PubMed ID: 9644268
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
17. Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.
Takahashi Y; Horio H; Sakaguchi K; Hiramatsu K; Kawakita M
BMC Cancer; 2015 Feb; 15():65. PubMed ID: 25884987
[TBL] [Abstract][Full Text] [Related]
18. Determination of amounts of polyamines excreted in urine: demonstration of N1,N8-diacetylspermidine and N1,N12-diacetylspermine as components commonly occurring in normal human urine.
Hiramatsu K; Sugimoto M; Kamei S; Hoshino M; Kinoshita K; Iwasaki K; Kawakita M
J Biochem; 1995 Jan; 117(1):107-12. PubMed ID: 7775374
[TBL] [Abstract][Full Text] [Related]
19. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas].
Yamaguchi K; Nagano M; Torada N; Hamasaki N; Kawakita M; Tanaka M
Rinsho Byori; 2004 Apr; 52(4):336-9. PubMed ID: 15164602
[TBL] [Abstract][Full Text] [Related]
20. Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer.
Malmström PU; Larsson A; Johansson S
Br J Urol; 1993 Sep; 72(3):307-10. PubMed ID: 8220992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
